References
- Anderson VE. Obituary: Sheldon Reed, Ph.D. (7 November 1910–1 February 2003): genetic counseling, behavioral genetics. Am. J. Hum. Genet. 73(1), 1–4 (2003).
- Resta R. A new definition of genetic counseling: National Society of Genetic Counselors’ Task Force report. J. Genet. Couns. 15(2), 77–83 (2006).
- Matloff ET. From the guest editor: cancer genetic counseling and testing: past, present, and future. Cancer J. 18(4), 285–286 (2012).
- Meiser B, Butow PN, Barratt AL et al.; Psychological Impact Collaborative Group. Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ. Couns. 44(3), 215–225 (2001).
- Bish A, Sutton S, Jacobs C, Levene S, Ramirez A, Hodgson S. Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women. Br. J. Cancer 86(1), 43–50 (2002).
- Schwartz MD, Isaacs C, Graves KD et al. Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer 118(2), 510–517 (2012).
- van Oostrom I, Meijers-Heijboer H, Lodder LN et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J. Clin. Oncol. 21(20), 3867–3874 (2003).
- United States Preventative Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann. Intern. Med. 143(5), 355–361 (2005).
- America Congress of Obstetricians and Gynecologists (ACOG). Practice bulletin no. 103: clinical management guidelines for hereditary breast and ovarian cancer syndrome. Obstet. & Gynecol. 113(4), 957–966 (2009).
- American Society of Clinical Oncologists (ASCO). ASCO policy statement update: genetic testing for cancer susceptibility. J. Clin. Oncol. 21(12), 2397–2406 (2003).
- National Coalition for Health Professional Education in Genetics (NCHPEG) and American Medical Association (AMA). Components of a cancer genetic counseling session (2012).
- Berliner JL, Fay AM, Cummings SA, Burnett B, Tillmanns T. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. J. Genet. Couns. 22(2), 155–163 (2013).
- King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645), 643–646 (2003).
- Domchek SM, Friebel TM, Singer CF et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9), 967–975 (2010).
- Smith KL, Isaacs C. BRCA mutation testing in determining breast cancer therapy. Cancer J. 17(6), 492–499 (2011).
- Kauff ND, Mitra N, Robson ME et al. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. J. Natl. Cancer Inst. 97(18), 1382–1384 (2005).
- Domchek SM, Gaudet MM, Stopfer JE et al. Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res. Treat. 119(2), 409–414 (2010).
- Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Health Expect. 11(3), 220–231 (2008).
- Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J. Natl Cancer Inst. 102(10), 680–691 (2010).
- Brierley KL, Campfield D, Ducaine W et al. Errors in delivery of cancer genetics services: implications for practice. Conn. Med. 74(7), 413–423 (2010).
- Brierley KL, Blouch E, Cogswell W et al. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer J. 18(4), 303–309 (2012).
- Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome. Semin. Oncol. 34(5), 428–434 (2007).
- Walsh T, Lee MK, Casadei S et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc. Natl Acad. Sci. USA 107(28), 12629–12633 (2010).
- Meiser B, Gaff C, Julian-Reynier C et al. International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis. 27, 109–125 (2006).
- Albada A, Werrett J, Van Dulmen S et al. Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands? J. Community Genet. 2(4), 233–247 (2011).
- Parthasarathy S. Architectures of genetic medicine: comparing genetic testing for breast cancer in the USA and the UK. Soc. Stud. Sci. 35(1), 5–40 (2005).
- Hollestelle A, Wasielewski M, Martens JW, Schutte M. Discovering moderate-risk breast cancer susceptibility genes. Curr. Opin. Genet. Dev. 20(3), 268–276 (2010).
- O’Daniel JM, Lee K. Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling. Cancer J. 18(4), 287–292 (2012).
- Green RC, Berg JS, Grody WW et al. ACMG recommendations for reporting incidental findings of clinical exome or whole genome sequencing. Am. Coll. Med. Genet. Genom. 1–29 (2013).
Websites
- Farell R. 10 Jobs of the Future. AOL Jobs (2011). http://jobs.aol.com/articles/2011/03/10/10-jobs-of-the-future (Accessed 3 January 2013)
- Webley K. Nine Jobs of the (Near) Future. Time Magazine (2011). http://business.time.com/2011/11/21/nine-jobs-of-the-near-future/slide/genetic-counselors/ (Accessed 3 January 2013)
- Sato R. Future ‘Top 10’ Hot Careers in 2012: Space Tourism to Genetic Counseling (2008). www.dailygalaxy.com/my_weblog/2008/08/future-top-10-h.html (Accessed 3 January 2013)
- National Society of Genetic Counselors. 2012 Professional Status Survey (2012). www.nsgc.org
- National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Genetic/Familial High Risk Assessment: Breast and Ovarian (version 2.2013) (2013). www.nccn.org/professionals/physcian_gls/genetics_screening.pdf
- American College of Surgeons (ACS) Commission on Cancer 2012 Standards (2012). www.facs.org/cancer/cocsource/2012/february.html (Accessed 20 January 2013)
- Facing Our Risk For Cancer Empowered (FORCE) Press Release. Gene Patenting Lawsuit Against Myriad Genetics (2012). www.facingourrisk.org/advocacy/current_action/gene_patenting.php (Accessed 1 March 2013)
- Department of Health and Human Services. Preventive Services Covered Under the Affordable Care Act (2010). www.healthcare.gov/news/factsheets/2010/07/preventive-services-list.html (Accessed 1 March 2013)
- Myriad Genetics Press Release: BRCA Testing Granted Preventive Care Designation Under the Affordable Care Act (2013). http://globenewswire.com/news-release/2013/03/06/528521/10024193/en/BRCA-Testing-Granted-Preventive-Care-Designation-Under-the-Affordable-Care-Act.html (Accessed 7 March 2013)
- Department of Health and Human Services. GINA: The Genetic Information Nondiscrimination Act of 2008, Information for Researchers and Health Care Professionals (2009). www.genome.gov/Pages/PolicyEthics/GeneticDiscrimination/GINAInfoDoc.pdf (Accessed 2 May 2013).
- Schultz D. It’s Legal For Some Insurers To Discriminate Based On Genes. National Public Radio (2013). www.npr.org/blogs/health/2013/01/17/169634045/some-types-of-insurance-can-discriminate-based-on-genes (Accessed 20 January 2013)